Lilly QC/QA department
Lilly VP-Commercialization Networks Frank Deane, PhD, named VP-quality, succeeding Alan Dinner, PhD, who is retiring from the company. Deane and VP-Manufacturing Scott Canute will manage Lilly's responses to FDA on recent manufacturing issues raised by the agency ("The Pink Sheet" March 12, p. 26). Canute and Deane both report to Senior VP-Human Resources & Manufacturing Pedro Granadillo...
You may also be interested in...
Lilly hopes to be ready for a re-inspection of its intramuscular Zyprexa production facility in mid-May, ahead of the late June user fee deadline for a decision on the new formulation of the antipsychotic.
In this week's podcast episode of Five Must-Know Things, hear about issues surrounding the proposed IP waiver for coronavirus vaccines, a trial delay for Novavax’s COVID-19 vaccine, an ICER review of multiple myeloma drugs and Galapagos’ efforts to refocus its R&D pipeline.
Private Company Edition: Perceptive/Xontogeny, Abingworth, Kizoo and Droia closed venture capital funds. New biopharma VC financings also include a $105m series C round for Elpiscience and $92m for newly launched Interline.